Careers
By joining Lonza, you will get to work with some of the world’s top experts in the space, while developing advanced therapies with a potentially life-saving outcome.
Behnam Ahmadian Baghbaderani
Global Head of Process Development
From a manufacturing stand-point, the challenge resides not only in the production but also in the characterization. Exosomes have the potential to make cell and gene therapies commercially viable for large populations.
We are still at a very early stage and most developers of these innovative technologies are in pre-clinical or early clinical stages, working to demonstrate the efficacy and the potential of exosomes-based therapies.
Bringing next-generation processes to innovators
Leverage a high-yield perfusion-based process: intensified continuous biomanufacturing
- Very high cell density and productivity
- High viability – high purity
- Small footprint
- Low residence time
Source: Codiak Biosciences.
Process under license and available to Lonza customers.
Our locations
Locations providing exosomes services
Cell and Gene
Related Insights
